Whether its analyzing the large genomic datasets or supporting the researchers in the life science space, the biotech industry is nudging its way with the technological advancements. When it comes to navigating through the innovative technology in the life science space, Golden Helix is the pathfinder. With over 18 years of experience in bioinformatics and translational medicine, Golden Helix provides software and analytics services empowering the clinical researchers and healthcare professionals in the biotech industry.
Golden Helix facilitates the genetic research and translational genomics company to design high-quality software and perform high-end analytics work. The company offers a broad range of products which accelerates the process of analyzing the next-generation sequencing data and creation of clinical reports. The suite of products includes SNP & Variation Suite (SVS), VarSeq, and GenomeBrowse which encourages biologists, clinicians, and other researchers to carry out complex analyses and visualizations. The Golden Helix products eliminate the dependence on bioinformatics experts as the products are integrated and robust.
“With our portfolio of products, hundreds of the world's top pharmaceutical, biotech, and academic research organizations can harness the full potential of genomics,” says Andreas Scherer, President & CEO, Golden Helix. The company’s software products assist the healthcare professionals in identifying the cause of disease, improving the efficiency and safety of drugs, developing genomic diagnostics, and advance the quest for personalized medicine.
Apart from testing labs, hospitals, pharmaceutical companies, research organizations, and government organizations, Golden Helix also works collaboratively with universities and colleges. The firm supports R&D efforts in universities and also brings the technology to the market developed by university researchers.